Business Description
Compare
Compare
Traded in other countries / regions
BGLA.GermanyBIOG B.Sweden0GTN.UKBGAIF.USA IPO Date
2013-05-29Description
BioGaia AB is a healthcare company. It develops, markets and sells probiotic products. The company segmented its operating activities into three reportable segments, Pediatrics, Adult Health, and other. Paediatrics segment comprised of digestive health tablets, oral rehydration solution, and cultures as an ingredient in a licensee's product and royalties from pediatric health products. Adult Health business unit comprises digestive health tablets, oral health lozenges, cultures as an ingredient in a licensee's dairy products. The other segment consists of royalties in respect of development projects and animal health products. Its primary geographic markets are Europe, USA and Canada, Asia, and Rest of World.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.89 | |||||
| Interest Coverage | 67.11 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 26 | |||||
| Beneish M-Score | -2.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.5 | |||||
| 3-Year EBITDA Growth Rate | 16.9 | |||||
| 3-Year EPS without NRI Growth Rate | 19.9 | |||||
| 3-Year FCF Growth Rate | 33.7 | |||||
| 3-Year Book Growth Rate | 49.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.36 | |||||
| 9-Day RSI | 38 | |||||
| 14-Day RSI | 41.28 | |||||
| 6-1 Month Momentum % | 22.79 | |||||
| 12-1 Month Momentum % | -7.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.88 | |||||
| Quick Ratio | 10.88 | |||||
| Cash Ratio | 9.01 | |||||
| Days Inventory | 124.16 | |||||
| Days Sales Outstanding | 39.21 | |||||
| Days Payable | 51.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.78 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| 3-Year Dividend Growth Rate | -3.6 | |||||
| Forward Dividend Yield % | 0.78 | |||||
| 5-Year Yield-on-Cost % | 0.56 | |||||
| 3-Year Average Share Buyback Ratio | -5.2 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.64 | |||||
| Operating Margin % | 32.74 | |||||
| Net Margin % | 33.84 | |||||
| ROE % | 19.87 | |||||
| ROA % | 17.27 | |||||
| ROIC % | 43.56 | |||||
| ROC (Joel Greenblatt) % | 156.25 | |||||
| ROCE % | 22.66 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.05 | |||||
| PE Ratio without NRI | 25.77 | |||||
| Shiller PE Ratio | 38.77 | |||||
| Price-to-Owner-Earnings | 25.34 | |||||
| PEG Ratio | 4.16 | |||||
| PS Ratio | 8.5 | |||||
| PB Ratio | 4.76 | |||||
| Price-to-Tangible-Book | 5.31 | |||||
| Price-to-Free-Cash-Flow | 31.18 | |||||
| Price-to-Operating-Cash-Flow | 29.14 | |||||
| EV-to-EBIT | 17.44 | |||||
| EV-to-EBITDA | 16.58 | |||||
| EV-to-Revenue | 7.16 | |||||
| EV-to-FCF | 27.16 | |||||
| Price-to-Projected-FCF | 2.49 | |||||
| Price-to-Median-PS-Value | 0.84 | |||||
| Price-to-Graham-Number | 2.42 | |||||
| Price-to-Net-Current-Asset-Value | 5.98 | |||||
| Price-to-Net-Cash | 7.46 | |||||
| Earnings Yield (Greenblatt) % | 5.73 | |||||
| Forward Rate of Return (Yacktman) % | 5.25 |
How BioGaia AB (LTS:0GTN) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 1,103.958 | ||
| EPS (TTM) (kr) | 3.706 | ||
| Beta | 0.98 | ||
| Volatility % | 37.13 | ||
| 14-Day RSI | 41.28 | ||
| 14-Day ATR (kr) | 1.910876 | ||
| 20-Day SMA (kr) | 95.69091 | ||
| 12-1 Month Momentum % | -7.4 | ||
| 52-Week Range (kr) | 69 - 125.6 | ||
| Shares Outstanding (Mil) | 100.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioGaia AB Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioGaia AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioGaia AB Frequently Asked Questions
What is BioGaia AB(LTS:0GTN)'s stock price today?
The current price of LTS:0GTN is kr93.06. The 52 week high of LTS:0GTN is kr125.60 and 52 week low is kr69.00.
When is next earnings date of BioGaia AB(LTS:0GTN)?
The next earnings date of BioGaia AB(LTS:0GTN) is 2023-05-05.
Does BioGaia AB(LTS:0GTN) pay dividends? If so, how much?
The Dividend Yield %  of BioGaia AB(LTS:0GTN) is 0.78% (As of Today), Highest Dividend Payout Ratio of BioGaia AB(LTS:0GTN) was 1.17. The lowest was 0.2. And the median was 0.38. The  Forward Dividend Yield % of BioGaia AB(LTS:0GTN) is 0.78%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
